Evolent Health

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Evolent Health excels in Q4 2022, eyes growth with Humana

Evolent Health posts strong financials, exceeding revenue and EBITDA targets.
Strategic partnerships and focus on organic growth drive value creation.
Challenges lie in maintaining growth momentum and effective execution.
Opportunities include margin expansion, capital optimization, and Humana partnerships.

Evolent Health surpasses Q1 expectations, eyes revenue growth opportunities

Evolent Health's Q1 performance exceeded expectations, driven by strong revenue growth and margin expansion initiatives. While facing challenges like revenue adjustments and Medicaid rebates, the company remains focused on capitalizing on growth opportunities through strategic partnerships and operational efficiencies.

Evolent Health excels in Q2, eyes $300M EBITDA target

Evolent Health's robust performance in Q2, strategic partnerships, and focus on organic growth position it well to achieve its financial targets.
Challenges lie in Medicaid membership declines, capital allocation optimization, and refinancing decisions amidst market uncertainties.
Opportunities in patient-centric care, CMS changes, and integrated entity approach offer avenues for growth and differentiation in the market.

Evolent Health surpasses Q3 expectations, eyes growth in specialty care

Evolent Health's Q3 performance exceeded expectations, driven by strong revenue growth and profitability, underpinned by strategic partnerships and a unique care model.
Despite challenges in ramping up Performance Suite adoption and maintaining cost control, the company's focus on growth and value creation positions it well for future success.
Opportunities in expanding specialty offerings and leveraging new partnerships highlight Evolent's growth potential and commitment to delivering value in the healthcare sector.

Evolent Health exceeds 2023 targets, eyes growth through partnerships

Evolent Health delivered strong financial results in Q4 2023, surpassing its 2023 targets and setting ambitious goals for 2024, driven by Specialty Care offerings and new revenue agreements.
While facing challenges related to medical utilization and new product launches, the company remains focused on organic growth and profitability, supported by a strategic approach to expansion.
Opportunities in cross-selling, new state expansions, and imaging capabilities position Evolent Health for continued growth and revenue diversification in the healthcare sector.

Evolent Health reports robust Q1 earnings, eyes margin improvements

Evolent Health's Q1 performance showcased strong revenue growth and EBITDA in line with guidance.
The company is optimistic about margin improvements, revenue expansion, and maintaining a balanced pipeline.
Challenges include margin impact from new go-lives and ongoing payer negotiations amid cost pressures.
Opportunities lie in improving gross margins, leveraging population changes, and focusing on cash flow expectations.

Evolent Health reports robust Q2 earnings, eyes growth opportunities ahead

Evolent Health's Q2 2024 earnings call highlighted strong financial performance, strategic initiatives, and a positive outlook for future growth. The company's focus on revenue diversification, margin optimization, and disciplined financial management positions it well for continued success in the evolving healthcare landscape.

Evolent Health revises outlook after Q3 challenges, secures financing

Evolent Health navigated higher medical costs impacting Q3 results, leading to a revised outlook for 2024. Despite challenges in managing expenses and oncology costs, the company remains committed to growth and securing new revenue agreements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q4 2020 Results - Earnings Call Transcript

The company released its quarterly update after the market closed on Thursday, and investors like what they saw.

Why Evolent Health Stock Is Jumping Today

WASHINGTON, Feb. 25, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter and full year ended December 31, 2020. Highlights from...

Evolent Health Announces Fourth Quarter and Full Year 2020 Results

WASHINGTON, Jan. 13, 2021 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (the "Company" or "Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it has entered a definitive agreement with Bright Health...

Evolent Health Enters Agreement with Bright HealthCare for Bright HealthCare to Acquire True Health New Mexico

WASHINGTON, Dec. 22, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) (the "Company" or "Evolent"), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that it has entered into a Cooperation Agreement with Engaged...

Evolent Health Announces Cooperation Agreement With Engaged Capital

Evolent Health, Inc. (EVH) CEO Seth Blackley on Q3 2020 Results - Earnings Call Transcript

CHICAGO--(BUSINESS WIRE)-- #maskup--Evolent Health, which supports over 375,000 Cook County Medicaid beneficiaries, is donating 10,000 face masks to community organizations on Nov. 9.

Evolent Health Partners with Community Organizations to Donate 10,000 Face Masks for Children and Families in Chicago

WASHINGTON, Oct. 22, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will release its third quarter 2020 operating results on Thursday, November 5, 2020...

Evolent Health, Inc. to Release Third Quarter 2020 Operating Results and Host Conference Call on Thursday, November 5, 2020

WASHINGTON, Sept. 21, 2020 /PRNewswire/ -- Evolent Health (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced it will host its annual Investor and Analyst Day on Tuesday, September 29, 2020, from 10:00 a.m....

Evolent Health to Host Virtual Investor and Analyst Day on September 29, 2020

Here's Why Evolent Health Dropped 10% on Friday

Evolent Health, Inc. (EVH) CEO Frank Williams on Q2 2020 Results - Earnings Call Transcript

Evolent Health (EVH) delivered earnings and revenue surprises of 70.00% and -1.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Reports Q2 Loss, Lags Revenue Estimates

WASHINGTON, July 31, 2020 /PRNewswire/ -- Done right, remote health advising and other care management interventions can significantly reduce hospitalizations and medical spend for high-risk Medicare beneficiaries, Evolent Health (NYSE: EVH) experts report in the July issue of The.

Data: Remote Care Management Lowered Hospital Visits, Health Costs for High-Risk Medicare Beneficiaries with Chronic Conditions

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Expected to Beat Earnings Estimates: Should You Buy?

Evolent Health sees its Relative Strength Rating hit the elite 90-plus level.
The post Stocks Showing Market Leadership: Evolent Health Earns 90 RS Rating appeared first on Investor's Business Daily.

Stocks Showing Market Leadership: Evolent Health Earns 90 RS Rating

The company is making lemonade out of the lemons that Kentucky's Medicaid program handed it.

Here's Why Evolent Health Jumped Higher Today

WASHINGTON, July 17, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced that Molina Healthcare, Inc.

Evolent Health Announces Agreement Between Molina Healthcare and Passport Health Plan for Molina to Acquire Certain Assets of Passport

WASHINGTON, July 13, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, has been named to the Parity.org Best Companies for Women to Advance List 2020. This list recognizes...

Evolent Health Named on Best Companies for Women to Advance List 2020 by Parity.org

New York, New York--(Newsfile Corp. - June 25, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company").Faruqi & Faruqi logoIf you invested in Evolent stock or op

Evolent Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolent Health, Inc. To Contact The Firm

New York, New York--(Newsfile Corp. - June 23, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company").Faruqi & Faruqi logoIf you invested in Evolent stock or options and would like to discuss your legal rights, click here:

Evolent Investor Alert: Faruqi & Faruqi, LLP   Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolent Health, Inc. To Contact The Firm

NEW YORK, June 8, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolent Health, Inc. ("Evolent" or "the Company") (NYSE: EVH). Investors who purchased Evolent securities are encouraged to obtain...

EVH Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Evolent Health, Inc. and Encourages Investors to Contact the Firm

Investors need to pay close attention to Evolent Health (EVH) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Evolent Health (EVH) Stock?

The healthcare administration company may lose a major partner.

Here's Why Evolent Health Shares Crashed Today

Evolent Health (NYSE: EVH) shares are trading lower on Monday. The company announced its partner, Passport Health Plan, was not selected for Kentucky managed Medicaid contract.

Why Evolent Health's Stock Is Trading Lower Today

Evolent Health, Inc. (EVH) CEO Frank Williams on Q1 2020 Results - Earnings Call Transcript

News for Evolent Health Stock (EVH)